Meningeal Neoplasms are tumors that grow on the membranes surrounding your brain and spinal cord. These tumors can be benign (not cancerous) or malignant (cancerous). They can cause symptoms like headache, seizures, and changes in mental function.
Every report comes from a Lived member, sent anonymously.
Have you had Craniotomy for Meningeal Tumors?
Meningeal tumors are growths in the meninges, the three thin layers of tissue that wrap and protect the brain and spinal cord. The term covers two very different situations, and knowing which one applies shapes almost everything else about diagnosis, treatment and outlook. The most common is a meningioma, a tumor that starts in the meninges themselves. Meningiomas are the most common type of primary brain tumor, and most are noncancerous and slow growing. They cause problems mainly by pressing on the brain, nerves or spinal cord as they enlarge, so symptoms depend on where they sit: headaches, seizures, changes in vision, hearing or smell, weakness, or changes in memory or personality. Many cause no symptoms at all and are found by chance on a scan done for another reason. Meningiomas are graded from 1 to 3. Grade 1 tumors are the most common and grow slowly. Grade 2 (atypical) tumors are more likely to come back after removal, and grade 3 (anaplastic) tumors are cancerous and grow quickly. The other situation is leptomeningeal metastasis, in which cancer from elsewhere in the body, most often breast cancer, lung cancer or melanoma, spreads into the inner membranes and the cerebrospinal fluid that bathes the brain and spinal cord. This is a complication of advanced cancer rather than a separate tumor, and it is far more serious than a typical meningioma.
The cause of most meningiomas is not known. They arise from changes in the genes of meningeal cells, and these changes usually happen by chance rather than being inherited. The clearest known risk factor is earlier radiation to the head, especially in childhood. Neurofibromatosis type 2, an inherited condition that causes tumors along nerves, also raises the risk, as do a few other rare inherited syndromes. Grade 1 meningiomas are more common in women, and risk rises with age. Higher-grade meningiomas occur more often in men and tend to appear around age 60. Having a risk factor does not mean a tumor will develop, and most people with a meningioma have none of them. Leptomeningeal metastasis happens only in people who already have cancer. The risk is highest with breast cancer, lung cancer and melanoma, particularly when the cancer has already spread to the brain.
A meningioma is usually first seen on MRI (magnetic resonance imaging), sometimes as an incidental finding. MRI with contrast dye shows the tumor's size, location and relationship to nearby nerves and blood vessels, which guides the decision about whether and how to treat. A neurological exam checks strength, sensation, vision, hearing, balance and thinking for signs that the tumor is affecting the nervous system. Imaging gives a provisional diagnosis; the exact type and grade are confirmed only when tissue removed during surgery is examined by a neuropathologist, a specialist in nervous system tumors. For suspected leptomeningeal metastasis, the main tests are contrast MRI of both the brain and the whole spine, and a lumbar puncture (spinal tap) to look for cancer cells in the cerebrospinal fluid. Neither test is perfect. The MRI can be normal even when cancer cells are present in the fluid, and a first fluid sample can miss them, so a second lumbar puncture is often done when suspicion remains.
For meningioma, treatment depends on the tumor's size, location, grade and symptoms, and on the person's age and health. Small meningiomas that cause no symptoms, particularly in older adults, are often monitored with repeat MRI scans rather than treated right away, since many grow very slowly or not at all. When treatment is needed, surgery is usually the first choice. Removing the whole tumor along with the patch of dura (the tough outer membrane) it grows from is often curative. Complete removal is not always safe when a tumor is wrapped around important nerves or blood vessels, and some tumor may be left behind deliberately. Radiation is used for tumors that cannot be fully removed, that come back, or that are grade 2 or 3. Stereotactic radiosurgery, sometimes known by device names such as Gamma Knife, delivers a concentrated dose to a small tumor in one or a few sessions, while fractionated radiotherapy is divided into many smaller daily doses for larger or more complex tumors. For meningiomas that keep growing after surgery and radiation, there is no standard drug treatment; options such as bevacizumab (Avastin), a drug that blocks blood vessel growth, have shown only modest results, and clinical trials are often discussed. For leptomeningeal metastasis, treatment is guided by the original cancer. Options include chemotherapy, targeted therapy or immunotherapy given by mouth or vein, chemotherapy delivered directly into the spinal fluid through a lumbar puncture or a small reservoir placed under the scalp, and radiation to areas causing symptoms. When fluid builds up in the brain (hydrocephalus), a shunt that drains it can relieve headache and other pressure symptoms. Treatment aims to extend life while preserving quality of life and slowing neurological decline, rather than to cure.
Many people with a grade 1 meningioma live with it for years with little effect on daily life, either because it is small and being watched or because surgery removed it. Recovery from brain surgery varies with the tumor's location, and some people have lasting effects such as seizures, fatigue, or changes in vision or other functions that need rehabilitation. Meningiomas can return, especially when some tumor was left behind or the grade is higher, so follow-up MRI scans continue for years after treatment. The outlook for grade 2 and 3 meningiomas is more guarded. In the United States, about 64 percent of adults with a high-grade meningioma are alive five years after diagnosis, though this varies widely with grade, age, location and how much tumor could be removed. Leptomeningeal metastasis is a serious diagnosis. Survival has typically been measured in months, though it varies with the type of cancer and how it responds to treatment. Some people whose cancer carries a change that a targeted drug can act on, such as certain lung cancers, have lived considerably longer. Because time and comfort matter so much, palliative care that manages pain, nausea and other symptoms is often involved alongside cancer treatment.
See a clinician if you have new, persistent headaches that are worse in the morning, or gradual changes in vision, hearing, smell, balance, memory or personality. If you have a known meningioma, report any new or changing symptoms to your care team promptly rather than waiting for the next scan. If you are being treated for breast cancer, lung cancer or melanoma, contact your oncology team promptly about new headaches with nausea or vomiting, double vision, facial weakness, hearing loss, trouble walking, back or neck pain that spreads down a limb, bladder problems or confusion. Call 911 for a first-ever seizure, a seizure lasting longer than a few minutes, or when someone does not wake up normally after a seizure.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Meningeal Tumors is like, what's helped you, or ask the community a question.